Behind the Yield

The Emerson Files, Part 1 of 4

By Charles Urquhart, CFA · April 22, 2026

The Emerson Files / Part 1 of 4

How I Found Emerson

I went looking for the unnamed distributor of a $15 billion BlackRock fund. What I found was a firm with a story that nobody was telling.

By Charles Urquhart, CFA

April 2026

A few weeks back, I published a three-part series on Class F shares in the HPS Corporate Lending Fund (HLEND). The non-traded BDC sold Class F shares to the public for $5.9 billion in capital and with a 0.50% annual distribution fee. Furthermore, these shares can only be purchased through a single entity called the "Founding Distributor."

No company name. No CRD number.

For the other BDCs I've written about in the past, the company who managed the sale of the BDC's shares to investors has been named in their prospectuses. For instance, Blackstone Private Credit Fund's dealer manager is named in its prospectus: Blackstone Securities Partners. Similarly, Blue Owl Credit Income Corp's dealer manager is named: Blue Owl Securities. Apollo Debt Solutions' dealer manager is Apollo Global Securities. HLEND's prospectus does not name the entity distributing 43% of its outstanding shares. It calls them the "Founding Distributor."

So I went looking.

According to the prospectus for HLEND, the "Founding Distributor" is defined as the participating broker with whom the Fund was launched on an exclusive basis in 2022. Furthermore, HLEND's debut with its escrow was on February 3, 2022. During this time, the company was represented by only one broker-dealer: Emerson Equity LLC of San Mateo, California.

The two companies entered into a managing dealer agreement on August 3, 2021. Emerson served as the managing dealer for HLEND from its founding. That agreement was terminated effective April 11, 2024, when HPS Securities, an HPS affiliate, took over. Then, BlackRock acquired HPS on July 1, 2025. Yet the Class F shares continued to have their Founding Distributor. The language never changed. The Founding Distributor was never named. And the shares kept growing.

I had my answer. The firm that launched HLEND with an exclusive agreement in 2022, who was the company's only broker-dealer during its founding, and the managing dealer named in the company's initial registration statement was Emerson Equity LLC.

And then I made a mistake.

I searched BrokerCheck.

The firm I was expecting to find on BrokerCheck was a small company that had some relationship with HPS and which had distributed shares of the company to investors. Perhaps it would have a couple of disclosures on the firm's BrokerCheck profile regarding the shares it distributed and managed. I was expecting something clean and simple.

What I found was anything but.

First, the sole control person of the firm was under a FINRA suspension during the month that HLEND launched. Second, the SEC found in August 2025 that the firm willfully violated Regulation Best Interest in the sale of corporate bonds to retail customers, including to an 85-year-old who invested 40% of her liquid net worth in 7-year corporate bonds. Furthermore, the company had served as the managing broker-dealer for a $2 billion bond offering that later went to zero and caused 26,000 investors to recover less than three cents on the dollar. Separately, Emerson served as the sole managing broker-dealer for a healthcare real estate company's securities offerings. That company filed for bankruptcy in February 2026, with total liabilities of between $1 billion and $10 billion.

In addition, the firm had at least 17 current and former registered representatives with customer complaints on their BrokerCheck profiles, spanning corporate debt, real estate, alternative investments, and alleged elder financial abuse.

On its financial statements, the company reported $96 million in revenue for 2025, $0 in reserves against pending litigation, and its managing member distributed $500,000 in January 2026 while arbitration disputes between the firm and its clients were ongoing.

According to its Form ADV, which was amended on April 8, 2026, the firm disclosed nine separate "Yes" answers on its disciplinary history and confirmed that a new regulatory proceeding is currently pending.

All of this from public records. All of this available to any financial advisor who knew where to look for this information.

The problem is that the prospectus never gave them the name to search.

This series of articles is not about HLEND. Yes, I have written several articles on the Class F shares and on the company that distributed them. Yet HLEND continues to perform well in the market and is managed by one of the best credit departments in the country. HPS was acquired by the world's largest asset manager in 2025.

This is about the firm I found when I went looking for the Founding Distributor. This is about Emerson Equity LLC. The products it distributed to retail investors. The way in which they were sold. The individuals who sold them. The outcome of the clients who bought them.

This series of articles used only primary sources to present the information published about the firm. All of the information is based upon filings from the SEC, FINRA, BrokerCheck, audited financial statements, and the case descriptions that attorneys involved in pending litigation have published. All pending legal issues are unproven allegations and are noted as such. Settlements referenced were not admissions of wrongdoing. I am not a lawyer. I did not go into this endeavor to become one. After spending 30 years in the world of institutional investing, I am concerned by the findings about this firm.

In Part 2 of this series, I will discuss Emerson's two main products: the GWG L Bonds and the Inspired Healthcare Capital DST offerings. Both were distributed by the firm to retail investors. Both ended in bankruptcy. Together, they represent more than $3 billion in investor exposure and over $1 billion in estimated losses.

The machine that distributed these products to the public is the subject of this series.

Wall Street is spending billions to bring private credit to retail investors. The question nobody is asking is who is bringing it to them.

Next: The Emerson Files, Part 2: "The Machine"

The two products that were distributed by the firm to retail investors. The seminars on which they advertised their offerings. The $2 billion bond offering that their firm managed that became worth $0. And the firm behind all of this.

Charles Urquhart, CFA, is the founder of Fixed Income Resources and an adjunct professor of Fixed Income Securities at Loyola University Maryland's Sellinger School of Business. Mr. Urquhart spent 30 years in the industry as a specialist on the institutional trading desks at Kidder Peabody, Lehman Brothers, Fidelity Capital Markets, Tradeweb, and Andrew Davidson & Co. Mr. Urquhart does not have a position in HLEND, no business relationships with Emerson Equity, HPS, or BlackRock, and has no financial interest in any of the litigation pending before the SEC and FINRA.